Complete remission induction with combined VBMCP chemotherapy and interferon (rIFNα2b) in patients with multiple myeloma

Martin M. Oken, Robert A. Kyle, Philip R. Greipp, Neil E. Kay, Anastasios Tsiatis, Stephanie A. Gregory, Robert J. Spiegel, Michael J. O'connell

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN<sub>α2b</sub>) in patients with multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences